DASHENLIN PHARMACEUTICAL GROUP CO., LTD.

Share ownership DaShenLin Pharmaceutical Group Co., Ltd.

603233

CNE100002RG2

Drug Retailers

End-of-day quote Shanghai S.E. Other stock markets 13/02/2026			5-day change	1st Jan Change
19.22 ^CNY	-1.44%		-2.09%	+9.08%

29/10/25	DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025	CI
28/08/25	DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025	CI

Share class: DaShenLin Pharmaceutical Group Co., Ltd.

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	1,138,847,895	381,433,013 ( 33.49 %)	0	33.49 %

Major shareholders: DaShenLin Pharmaceutical Group Co., Ltd.

Name	Equities	%	Valuation
Yun Feng Ke 21.33 %	242,591,847	21.33 %	698 M ¥
Jin Long Ke 18.19 %	206,931,849	18.19 %	596 M ¥
Kang Bao Ke 15.67 %	178,192,742	15.67 %	513 M ¥
Zhou Ke 3.606 %	41,011,200	3.606 %	118 M ¥
Aegon-Industrial Fund Management Co., Ltd. 2.795 %	31,786,886	2.795 %	91 M ¥
Ming Song 1.94 %	22,058,318	1.94 %	63 M ¥
Jing Rong Liu 1.66 %	18,882,879	1.66 %	54 M ¥
Jiaying Liang 1.05 %	11,937,444	1.05 %	34 M ¥
Chao Zhu Zou 0.9129 %	10,382,045	0.9129 %	30 M ¥
Xiao Ling Liang 0.8636 %	9,822,243	0.8636 %	28 M ¥
░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Breakdown by shareholder type

Individuals	66.79%
Institutional	6.15%
Unknown	27.06%

Based on 1000 largest holdings

Geographical origin of shareholders

Individuals	66.78%
China	5.72%
Ireland	0.17%
Singapore	0.1%
United Kingdom	0.1%
Hong Kong	0.06%
Taiwan	0.01%

Based on 1000 largest holdings

DaShenLin Pharmaceutical Group Co Ltd is a China-based company principally engaged in the pharmaceutical retailing business. The Company's primary business includes direct sales and retailing of Chinese and Western medicine, ginseng nourishing herbs and Chinese medicine pieces, health products, medical apparatus and instruments and other commodities. The Company mainly conducts its business within domestic market.

Employees

43,532

Sector

Drug Retailers

Calendar

04-22 - Q1 2026 Earnings Release (Projected)

More about the company